Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1987 Sep;71(9):647–650. doi: 10.1136/bjo.71.9.647

Characterisation of ocular melanoma with cutaneous melanoma antibodies.

J Bomanji 1, A Garner 1, J Prasad 1, D M Albert 1, J L Hungerford 1, M Granowska 1, K E Britton 1
PMCID: PMC1041267  PMID: 3311140

Abstract

It can be difficult to distinguish between various forms of pale intraocular tumour, and in particular between an amelanotic malignant melanoma, a choroidal haemangioma, and a solitary metastasis. If a monoclonal antibody specific for melanoma could be identified, it might be radiolabelled to provide a scanning technique which could distinguish between an ocular melanoma and a similar lesion. This pilot, in vitro study was undertaken to determine if monoclonal antibody against cutaneous melanoma recognises any antigenic similarity in ocular melanomas. Three cutaneous melanoma MoAbs 225.28S, 376.96S, and 763-24T and a non-specific MoAb HMFG2 were studied. Cell impressions were obtained from fresh ocular malignant melanomas. Standard staining techniques with immunofluorescence were used. MoAb 225.28S, 376.96S, and 763.24T were positive in melanomas with a dominant epithelioid cell type and in those with a dominant spindle cell type. It is concluded that MoAb 225.28S, 376.96S, and 763.24T may be suitable for imaging ocular melanomas after labelling with 123I, 111In, or 99mTc.

Full text

PDF
647

Images in this article

648Image
on p.648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert D. M., Ruzzo M. A., McLaughlin M. A., Robinson N. L., Craft J. L., Epstein J. Establishment of cell lines of uveal melanoma. Methodology and characteristics. Invest Ophthalmol Vis Sci. 1984 Nov;25(11):1284–1299. [PubMed] [Google Scholar]
  2. Bumol T. F., Reisfeld R. A. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1245–1249. doi: 10.1073/pnas.79.4.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buraggi G., Turrin A., Cascinelli N., Attili A., Gasparini M., Callegaro L., Ferrone S., Seregni E., Bombardieri E., Belli F. Radioimmunodetection of melanoma: preliminary results of a prospective study. Int J Biol Markers. 1986 Jan-Apr;1(1):47–54. doi: 10.1177/172460088600100108. [DOI] [PubMed] [Google Scholar]
  4. Char D. H., Stone R. D., Irvine A. R., Crawford J. B., Hilton G. F., Lonn L. I., Schwartz A. Diagnostic modalities in choroidal melanoma. Am J Ophthalmol. 1980 Feb;89(2):223–230. doi: 10.1016/0002-9394(80)90115-4. [DOI] [PubMed] [Google Scholar]
  5. Dippold W. G., Lloyd K. O., Li L. T., Ikeda H., Oettgen H. F., Old L. J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6114–6118. doi: 10.1073/pnas.77.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farrands P. A., Perkins A. C., Pimm M. V., Embleton M. J., Hardy J. D., Baldwin R. W., Hardcastle J. D. Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. Lancet. 1982 Aug 21;2(8295):397–400. doi: 10.1016/s0140-6736(82)90437-8. [DOI] [PubMed] [Google Scholar]
  7. Granowska M., Britton K. E., Shepherd J. H., Nimmon C. C., Mather S., Ward B., Osborne R. J., Slevin M. L. A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer. J Clin Oncol. 1986 May;4(5):730–736. doi: 10.1200/JCO.1986.4.5.730. [DOI] [PubMed] [Google Scholar]
  8. Ng A. K., Giacomini P., Kantor R., Ferrone S. Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies. Clin Chem. 1982 Dec;28(12):2347–2350. [PubMed] [Google Scholar]
  9. Robertson D. M., Campbell R. J. Errors in the diagnosis of malignant melanoma of the choroid. Am J Ophthalmol. 1979 Mar;87(3):269–275. doi: 10.1016/0002-9394(79)90060-6. [DOI] [PubMed] [Google Scholar]
  10. Seeger R. C., Rosenblatt H. M., Imai K., Ferrone S. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies. Cancer Res. 1981 Jul;41(7):2714–2717. [PubMed] [Google Scholar]
  11. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  12. Wilson B. S., Imai K., Natali P. G., Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer. 1981 Sep 15;28(3):293–300. doi: 10.1002/ijc.2910280307. [DOI] [PubMed] [Google Scholar]
  13. Wilson B. S., Ruberto G., Ferrone S. Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies. Cancer Immunol Immunother. 1983;14(3):196–201. doi: 10.1007/BF00205360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. de Muralt B., de Tribolet N., Diserens A. C., Stavrou D., Mach J. P., Carrel S. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens. Eur J Cancer Clin Oncol. 1985 Feb;21(2):207–216. doi: 10.1016/0277-5379(85)90175-0. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES